Recurrent Classical Hodgkin Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB06186Ipilimumab1Recruiting1
DB09035Nivolumab1Recruiting1
DB09037Pembrolizumab1Recruiting1
DB02546Vorinostat1Recruiting1
DB08870Brentuximab vedotin1 / 2Suspended1
DB06186Ipilimumab1 / 2Suspended1
DB09035Nivolumab1 / 2Suspended1
DB09035Nivolumab2Recruiting1
DB09037Pembrolizumab2Recruiting1
DB08877Ruxolitinib2Recruiting1